Last reviewed · How we verify

NCT03700619

Executive Functions and Preterm Children in 11 to 12 Year Old

Completed Last updated 10 September 2021
What this trial tests

trial testing BRIEF parental survey in Preterm Infant in 355 participants. Completed in 1 June 2019.

Timeline
30 January 2019
Primary endpoint
1 June 2019
1 June 2019

Quick facts

Lead sponsorNantes University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment355
Start date30 January 2019
Primary completion1 June 2019
Estimated completion1 June 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Nantes University Hospital

Who can join

Adults 11 to 12, any sex, with Preterm Infant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Preterm children have a high risk for neurodevelopmental impairments. The impact on motor functions and neurosensory functions is demonstrated but the incidence of executive functions is not described for preterm infants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of BRIEF parental survey

Trials testing the same drug.

Other recruiting trials for Preterm Infant

Currently open trials in the same condition.

Other Nantes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03700619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing